Worth reading
46Recurring
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
333000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Report on the acquisition and extinguishment of Stock Acquisition Rights issued through a third-party allotment
Who receives how much
Series 5 Stock Acquisition Rights: 133,000 common shares; Series 6 Stock Acquisition Rights: 200,000 common shares (333,000 shares in total)
EVO FUND (1,330 Series 5 rights and 2,000 Series 6 rights)
The lower thin line represents the existing number of shares to which these shares will be added.
Terms of the stock acquisition rights
Exercise period
Through 15 June 2026 (expired on that date)
Number of Stock Acquisition Rights
Acquired and extinguished: 1,330 Series 5 rights and 2,000 Series 6 rights
Most recent equity financing
Series 4 through Series 6 Stock Acquisition Rights were issued on 29 May 2023 for the purpose of raising funds; the amount is not stated in this document
Impact on Business Performance
The impact on results for the fiscal year ending March 2026 is expected to be immaterial
| Item | Details |
|---|---|
| Type of issuance or disposal | Report on the acquisition and extinguishment of Stock Acquisition Rights issued through a third-party allotment |
| Number of shares to be issued or disposed of | Series 5 Stock Acquisition Rights: 133,000 common shares; Series 6 Stock Acquisition Rights: 200,000 common shares (333,000 shares in total) |
| Intended allottee | EVO FUND (1,330 Series 5 rights and 2,000 Series 6 rights) |
| Exercise period | Through 15 June 2026 (expired on that date) |
| Number of Stock Acquisition Rights | Acquired and extinguished: 1,330 Series 5 rights and 2,000 Series 6 rights |
| Most recent equity financing | Series 4 through Series 6 Stock Acquisition Rights were issued on 29 May 2023 for the purpose of raising funds; the amount is not stated in this document |
| Impact on Business Performance | The impact on results for the fiscal year ending March 2026 is expected to be immaterial |
Items this document does not state (21)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidExercise priceTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offering
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Because the exercise period expired on 15 June 2026, the Company acquired all remaining Stock Acquisition Rights pursuant to the issuance terms, and they were extinguished on 16 June 2026.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.